XML 47 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock Award Plans (Tables)
12 Months Ended
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Cost Breakdown in Statement of Earnings
The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statement of earnings for stock awards for the years ended December 31, 2017, 2016 and 2015 were as follows (in thousands):

  
2017
  
2016
  
2015
 
Compensation cost
 
$
11,460
  
$
11,675
  
$
11,104
 
Income tax benefit
 
$
4,333
  
$
4,378
  
$
4,120
 
Summary of Stock Option Valuation Assumptions
The key input variables used in valuing the stock options during the years ended December 31, 2017, 2016 and 2015 were as follows:

  
2017
  
2016
  
2015
 
Dividend yield
 
None
  
None
  
None
 
Average risk-free interest rate
  
2.0
%
  
1.5
%
  
1.3
%
Stock price volatility
  
27
%
  
30
%
  
33
%
Estimated option term
 
Six years
  
Six years
  
Six years
 
Employee Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activity
The following is a summary of the stock option activity under the employee plan described above for the years ended December 31, 2017, 2016 and 2015:

  
Outstanding
Non-
Qualified or
Nonincentive
Stock
Awards
  
Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2014
  
322,956
  
$
69.95
 
Granted
  
114,894
  
$
74.99
 
Canceled or expired
  
(7,418
)
 
$
86.28
 
Outstanding at December 31, 2015
  
430,432
  
$
71.01
 
Granted
  
186,706
  
$
53.50
 
Canceled or expired
  
(16,017
)
 
$
80.17
 
Outstanding at December 31, 2016
  
601,121
  
$
65.33
 
Granted
  
123,141
  
$
68.46
 
Exercised
  
(36,616
)
 
$
47.95
 
Canceled or expired
  
(32,991
)
 
$
74.07
 
Outstanding at December 31, 2017
  
654,655
  
$
66.45
 
Summary of Outstanding and Exercisable Stock Options
The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at December 31, 2017:

   
Options Outstanding
  
Options Exercisable
 
Range of Exercise Prices
  
Number
Outstanding
  
Weighted
Average
Remaining
Contractual
Life in
Years
  
Weighted
Average
Exercise
Price
  Aggregated
Intrinsic
Value
  
Number
Exercisable
  
Weighted
Average
Exercise
Price
  Aggregated
Intrinsic
Value
 
$
46.74 – $51.23
   
197,776
   
3.8
  
$
50.02
       
100,806
  
$
48.86
      
$
64.65 – $74.99
   
394,704
   
4.0
  
$
69.68
       
217,627
  
$
70.25
      
$
93.64 – $96.85
   
33,987
   
3.1
  
$
94.31
       
33,987
  
$
94.31
      
$
101.46 – $104.37
   
28,188
   
3.2
  
$
102.88
       
28,188
  
$
102.88
      
$
46.74 – $104.37
   
654,655
   
3.8
  
$
66.45
  $
3,455,000
   
380,608
  
$
69.15
  $
1,883,000
 
 
Summary of Restricted Stock Award Activity
The following is a summary of the restricted stock award activity under the employee plan described above for the years ended December 31, 2017, 2016 and 2015:

  
Unvested
Restricted
Stock Award
Shares
  
Weighted
Average
Grant Date
Fair Value
Per Share
 
Nonvested balance at December 31, 2014
  
321,453
  
$
71.04
 
Granted
  
122,740
  
$
75.04
 
Vested
  
(113,958
)
 
$
60.73
 
Forfeited
  
(18,508
)
 
$
82.00
 
Nonvested balance at December 31, 2015
  
311,727
  
$
75.73
 
Granted
  
190,610
  
$
53.56
 
Vested
  
(105,109
)
 
$
69.93
 
Forfeited
  
(19,573
)
 
$
76.06
 
Nonvested balance at December 31, 2016
  
377,655
  
$
66.14
 
Granted
  
127,255
  
$
68.50
 
Vested
  
(105,600
)
 
$
68.91
 
Forfeited
  
(35,189
)
 
$
69.45
 
Nonvested balance at December 31, 2017
  
364,121
  
$
65.84
 

Director Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activity
The following is a summary of the stock option activity under the director plan described above for the years ended December 31, 2017, 2016, and 2015:

  
Outstanding
Non-
Qualified or
Nonincentive
Stock
Awards
  
Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2014
  
298,334
  
$
60.01
 
Exercised
  
(77,905
)
 
$
47.65
 
Outstanding at December 31, 2015
  
220,429
  
$
64.37
 
Exercised
  
(9,000
)
 
$
35.72
 
Canceled or expired
  
(6,000
)
 
$
99.52
 
Outstanding at December 31, 2016
  
205,429
  
$
64.60
 
Granted
  
3,188
  
$
70.65
 
Exercised
  
(39,000
)
 
$
46.23
 
Canceled or expired
  
(12,000
)
 
$
87.35
 
Outstanding at December 31, 2017
  
157,617
  
$
67.54
 
Summary of Outstanding and Exercisable Stock Options
The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at December 31, 2017:

   
Options Outstanding
  
Options Exercisable
     
Range of Exercise Prices
  
Number
Outstanding
  
Weighted
Average
Remaining
Contractual
Life in
Years
  
Weighted
Average
Exercise
Price
  Aggregate
Intrinsic
Value
  
Number
Exercisable
  
Weighted
Average
Exercise
Price
  Aggregate
Intrinsic
Value
 
$
29.60
   
6,000
   
1.3
  
$
29.60
       
6,000
  
$
29.60
      
$
41.24 – $56.45
   
53,276
   
2.4
  
$
52.77
       
53,276
  
$
52.77
      
$
61.89 – $62.48
   
35,153
   
4.5
  
$
62.31
       
35,153
  
$
62.31
      
$
70.65 – $99.52
   
63,188
   
6.0
  
$
86.50
       
62,391
  
$
86.71
      
$
29.60 – $99.52
   
157,617
   
4.3
  
$
67.54
  $
1,128,000
   
156,820
  
$
67.52
  $
1,128,000
 
Summary of Restricted Stock Award Activity
The following is a summary of the restricted stock award activity under the director plan described above for the years ended December 31, 2017, 2016 and 2015:

  
Unvested
Restricted
Stock
Award
Shares
  
Weighted
Average
Grant Date
Fair Value
Per Share
 
Nonvested balance at December 31, 2014
  
292
  
$
99.52
 
Granted
  
20,350
  
$
78.52
 
Vested
  
(18,851
)
 
$
79.77
 
Nonvested balance at December 31, 2015
  
1,791
  
$
68.73
 
Granted
  
23,074
  
$
64.89
 
Vested
  
(24,518
)
 
$
65.17
 
Nonvested balance at December 31, 2016
  
347
  
$
64.89
 
Granted
  
21,198
  
$
70.65
 
Vested
  
(21,226
)
 
$
70.56
 
Nonvested balance at December 31, 2017
  
319
  
$
70.65